
Vinblastine Sulfate
Form: Injection
Strength: 10 mg/10 mL (1 mg/mL), 10 mg/1 mL
Reference Brands: Velban® (EU & US)
Category: Oncology Cancer Care
Vinblastine Sulfate, marketed under the brand name Velban®, is a potent chemotherapy agent used in the treatment of Hodgkin and non-Hodgkin lymphoma, testicular cancer, Kaposi's sarcoma, and more. Available as an intravenous injection in strengths like 10 mg/10 mL, Vinblastine works by disrupting microtubule formation to inhibit cancer cell division. It is widely sourced by B2B pharmaceutical buyers across the US and EU, offering GMP-certified quality and consistent availability. Trusted in oncology protocols, Vinblastine is essential for hospitals and distributors seeking reliable cancer therapies through global supply chains.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsIfosfamide
Strength: 1 g/vial,2 g/vial, 3 g/vial
Form: Injection
Reference Brands: Ifex® (US), Holoxan® (EU)
View Details